The predictive role of plasma TGF-β1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer
- 29 February 2008
- journal article
- clinical trial
- Published by Elsevier BV in Lung Cancer
- Vol. 59 (2), 232-239
- https://doi.org/10.1016/j.lungcan.2007.08.010
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Does transforming growth factor-β1 predict for radiation-induced pneumonitis in patients treated for lung cancer?Cytokine, 2006
- Prevention of radiation-induced pneumonitis by recombinant adenovirus-mediated transferring of soluble TGF-β type II receptor geneCancer Gene Therapy, 2006
- Early Variations of Circulating Interleukin-6 and Interleukin-10 Levels During Thoracic Radiotherapy Are Predictive for Radiation PneumonitisJournal of Clinical Oncology, 2005
- Results of a phase I dose‐escalation study using three‐dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinomaCancer, 2005
- Transforming growth factor-β plasma dynamics and post-irradiation lung injury in lung cancer patientsRadiotherapy and Oncology, 2004
- Plasma transforming growth factor-?1 level before radiotherapy correlates with long term outcome of patients with lung carcinomaCancer, 1999
- Radiotherapy Alone for Medically Inoperable Stage I Non-Small–Cell Lung Cancer: The Duke ExperienceInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Plasma transforming growth factor-β1 reflects disease status in patients with lung cancer after radiotherapy: a possible tumor markerLung Cancer, 1996
- Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinomaLung Cancer, 1994
- Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung CancerThe New England Journal of Medicine, 1992